ABBV
$ABBV
AbbVie Inc.
Biopharmaceutical company known for Humira, Skyrizi, and Rinvoq immunology drugs.
Healthcare$208.86
-6.12 (-2.85%)
Day Range$207.71 - $214.56
Prev Close$214.98
Analyst Rating
Strong Buy
28 Buy / 11 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Apr 5
Weekly updates
Latest Report
ABBV: Dermatology & Aesthetics Growth Case (ABBV)
AbbVie ($ABBV) is supported by new dermatology and aesthetics data plus a healthy dividend and analyst optimism. Forward multiples and pipeline progress create upside, but valuation and execution risks remain.
Mar 30, 2026